Core Viewpoint - The report outlines the shareholding changes of Zhongzhu Medical Holdings Co., Ltd. due to the transfer of 100% equity of Landi Technology, which indirectly holds 19.08% of Zhongzhu Medical's shares, to Suzhou Bubugao. This transfer is driven by the need for funds by the disclosing party, Shenzhen Shenshang Holdings Group Co., Ltd. [1][6][10] Group 1 - The disclosing party has reduced its shareholding in Zhongzhu Medical through an indirect transfer of shares [1][2] - The disclosing party does not plan to increase or decrease its shareholding in the next 12 months [7] - The disclosing party has confirmed that there are no other means of increasing or decreasing its shareholding apart from what is disclosed in the report [2][5] Group 2 - The purpose of the equity change is to meet the disclosing party's funding needs [6] - The disclosing party held 380,172,862 shares of Zhongzhu Medical, representing 19.08% of the total share capital before the transfer [8][34] - After the transfer, the disclosing party will no longer hold any shares or voting rights in Zhongzhu Medical [9][10] Group 3 - The transfer agreement was signed on November 23, 2025, and involves the transfer of all rights and obligations associated with the 100% equity of Landi Technology [10][11] - The target company, Landi Technology, has been under judicial freeze since September 12, 2024, and the disclosing party is coordinating to lift this freeze [11][34] - The total assets of the target company as of June 30, 2025, were approximately 660 million RMB, with total liabilities of about 670 million RMB, resulting in a net asset of approximately -1 million RMB [12]
中珠医疗控股股份有限公司简式权益变动报告书